XML 23 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
8 NET INCOME (LOSS) PER SHARE
9 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
NET INCOME (LOSS) PER SHARE

NOTE 8.       NET INCOME (LOSS) PER SHARE:

 

A reconciliation of net income and weighted average shares used in computing basic and diluted net income per share is as follows: 

  Nine Months Ended  
  September 30,  
  2016     2015  
 

(in thousands,

except per share data)

 
Basic net income (loss) per share:          
Net income (loss) applicable to common shares   $ (0.32 )   $ 0.10  
Weighted average and common shares outstanding     12,794,149       9,992,828  
Basic net income (loss) per share of common stock   $ (0.32 )   $ 0.10  
Diluted net income (loss) per share:                
Net income (loss) applicable to common shares   $ (0.32 )   $ 0.10  
Weighted average and common shares outstanding     12,794,149       9,992,828  
Dilutive effects of convertible debt, stock options and warrants     -       -  
Weighted average common shares, assuming dilutive effect of stock options     12,794,149       9,992,828  
Diluted net income (loss) per share of common stock   $ (0.32 )   $ 0.10  


Share-based awards, inclusive of all grants made under the Company's equity plans, for which either the stock option exercise price or the fair value of the restricted share award exceeds the average market price over the period, have an anti-dilutive effect on earnings

per share, and accordingly, are excluded from the diluted computations for all periods presented.

 

As of September 30, 2016, there were approximately options to purchase 1,070,700 shares of the Company's common stock and restricted stock units for 590,869 shares of the Company's common stock, resulting in share-based awards for a total of 1,661,569 shares of our common stock, outstanding under the Plan leaving 338,431share-based units available under the Plan. During the nine months ended September 30, 2016, we granted our directors and employees options to purchase 970,700 shares of our common stock and restricted stock units for 590,869 shares of our common stock, resulting in aggregate grants under the Plan for 1,661,569 shares of our common stock.

 

Due to the Company's net loss, potential dilutive shares were not included in the calculation of diluted EPS on September 30, 2016, as it will have an antidilutive effect.